Human medicines European public assessment report (EPAR): Nplate, romiplostim, Date of authorisation: 04/02/2009, Revision: 29, Status: Authorised

Human medicines European public assessment report (EPAR): Heplisav B, hepatitis B surface antigen, Date of authorisation: 18/02/2021, Revision: 7, Status: Authorised

Human medicines European public assessment report (EPAR): Rukobia, fostemsavir, Date of authorisation: 04/02/2021, Revision: 5, Status: Authorised

EVVet3 EVWeb Production - Release notes

European Surveillance of Veterinary Antimicrobial Consumption (ESVAC): 2009 - 2023

List of centrally authorised products with safety-related changes to the product information

Human medicines European public assessment report (EPAR): Lydisilka, estetrol,drospirenone, Date of authorisation: 19/05/2021, Revision: 7, Status: Authorised

Human medicines European public assessment report (EPAR): Ontilyv, opicapone, Date of authorisation: 21/02/2022, Revision: 2, Status: Lapsed

Human medicines European public assessment report (EPAR): Kevzara, sarilumab, Date of authorisation: 23/06/2017, Revision: 15, Status: Authorised

HMPC: overview of assessment work - priority list